HomeDealsNegotiationsPolicyPipelineMoneyPeopleDataThe WeekPharmTech 100Deal TrackerResearch
The Week

GSK, Takeda and others notch key clinical wins in tough-to-treat diseases

From hepatitis B to melanoma, recent study results show innovative approaches are gaining ground.

By PharmaVoice · Jun 5, 2026 · via PharmaVoice
GSK, Takeda and others notch key clinical wins in tough-to-treat diseases

Image: PharmaVoice

This is an aggregated industry headline. Read the full story at PharmaVoice →

Tags
theweekformat:headlineheadlinePharmaVoice
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from The Week
All The Week →
As pro-life pressure ramps up on Trump, FDA is investigating safety of abortion pill: WSJ
The WeekFiercePharma ↗
As pro-life pressure ramps up on Trump, FDA is investigating safety of abortion pill: WSJ
The FDA is going forward with an investigation into the safety of the abortion pill mifepristone, an initiativ…
Jun 8, 2026
Roche bets $700M upfront on Nurix's late-phase BTK degrader to tee up Lilly showdown
The WeekFierceBiotech ↗
Roche bets $700M upfront on Nurix's late-phase BTK degrader to tee up Lilly showdown
Roche is paying Nurix Therapeutics $700 million upfront for rights to bexobrutideg, securing a stake in a BTK …
Jun 8, 2026
Medicare Advantage Expansion Slows but Deepens in 2026
The WeekBriefing
Medicare Advantage Expansion Slows but Deepens in 2026
Over half of eligible Medicare beneficiaries are now in Medicare Advantage, with growth concentrated in specia…
Jun 8, 2026